PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium

Cell-based regenerative therapies are significantly improved by engineering allografts to express factors that increase vascularization and engraftment, such as placental growth factor (PlGF) and matrix metalloproteinase 9 (MMP9). Moreover, the seeding of therapeutic cells onto a suitable scaffold i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bearzi, C, Gargioli, C, Baci, D, Fortunato, O, Shapira-Schweitzer, K, Kossover, O, Latronico, M V G, Seliktar, D, Condorelli, G, Rizzi, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944231/
https://www.ncbi.nlm.nih.gov/pubmed/24525729
http://dx.doi.org/10.1038/cddis.2014.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944231/
https://www.ncbi.nlm.nih.gov/pubmed/24525729
http://dx.doi.org/10.1038/cddis.2014.12

Ejemplares similares